Frankfurt - Delayed Quote EUR
RUA Life Sciences plc (AOHA.F)
0.1030
0.0000
(0.00%)
As of 8:03:22 AM GMT+2. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
2,191
2,191
2,179
1,625
1,528
Cost of Revenue
415
415
388
267
276
Gross Profit
1,776
1,776
1,791
1,358
1,252
Operating Expense
3,713
3,713
4,102
3,707
2,811
Operating Income
-1,937
-1,937
-2,311
-2,349
-1,559
Net Non Operating Interest Income Expense
-83
-83
-16
-8
-43
Pretax Income
-2,020
-2,020
-2,322
-2,360
-1,594
Tax Provision
-580
-580
-319
-293
-143
Net Income Common Stockholders
-1,440
-1,440
-2,003
-2,067
-1,451
Diluted NI Available to Com Stockholders
-1,440
-1,440
-2,003
-2,067
-1,451
Basic EPS
-0.04
-0.04
-0.09
-0.09
-0.08
Diluted EPS
-0.04
-0.04
-0.09
-0.09
-0.08
Basic Average Shares
33,546.5770
33,546.5770
22,184.7980
22,184.7980
17,697.1200
Diluted Average Shares
33,546.5770
33,546.5770
22,184.7980
22,184.7980
17,697.1200
Total Operating Income as Reported
-1,937
-1,937
-2,306
-2,352
-1,551
Total Expenses
4,128
4,128
4,490
3,974
3,087
Net Income from Continuing & Discontinued Operation
-1,440
-1,440
-2,003
-2,067
-1,451
Normalized Income
-1,440
-1,440
-2,007.3131
-2,064.3725
-1,458.2823
Interest Expense
83
--
--
--
--
Net Interest Income
-83
-83
-16
-8
-43
EBIT
-1,937
-1,937
-2,311
-2,349
-1,559
EBITDA
-1,573
-1,573
-1,953
-2,036
-1,287
Reconciled Cost of Revenue
415
415
388
267
276
Reconciled Depreciation
364
364
358
312
272
Net Income from Continuing Operation Net Minority Interest
-1,440
-1,440
-2,003
-2,067
-1,451
Total Unusual Items Excluding Goodwill
0
0
5
-3
8
Total Unusual Items
0
0
5
-3
8
Normalized EBITDA
-1,573
-1,573
-1,958
-2,033
-1,295
Tax Rate for Calcs
0.0003
0.0003
0.0001
0.0001
0.0001
Tax Effect of Unusual Items
0
0
0.6869
-0.3725
0.7177
3/31/2021 - 4/20/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade